Jay Wasman
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
-
- Thyroid Cancer Diagnosis and Treatment
Papers in
-
- Head and Neck Cancer Studies 16
-
- Lung Cancer Treatments and Mutations 5
- Brain Metastases and Treatment 4
- Co-authors
- Pierre LavertuScot C. RemickPingfu FuP. SavvidesAfshin DowlatiGovardhanan NagaiahFadi W. Abdul‐KarimAlan Siroy
- Journals
- Journal of Clinical Oncology (6 papers)Diagnostic Cytopathology (4 papers)The Laryngoscope (4 papers)American Journal of Otolaryngology (4 papers)Clinical Cancer Research (3 papers)
- Partner nations
- United StatesCanadaGreece
In The Last Decade
Jay Wasman
61 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 86
- Otorhinolaryngology 138
- Endocrinology, Diabetes and Metabolism 279
- Oncology 446
- Biochemistry 67
- Cancer Research 161
Countries citing papers authored by Jay Wasman
This map shows the geographic impact of Jay Wasman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Wasman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Wasman more than expected).
Fields of papers citing papers by Jay Wasman
This network shows the impact of papers produced by Jay Wasman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Wasman. The network helps show where Jay Wasman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jay Wasman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2022 | 15 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 4 | |
| 5 | 2020 | 15 | |
| 6 | 2019 | 20 | |
| 7 | 2019 | 6 | |
| 8 | 2019 | 35 | |
| 9 | 2019 | 1 | |
| 10 | 2017 | 7 | |
| 11 | 2017 | 14 | |
| 12 | 2012 | 45 | |
| 13 | 2011 | 47 | |
| 14 | 2010 | 25 | |
| 15 | 2008 | 9 | |
| 16 | 2007 | 15 | |
| 17 | 2005 | 23 | |
| 18 | 2003 | 4 | |
| 19 | A phase I pharmacokinetic and pharmacodynamic study of SU5416 and Adriamycin in inflammatory breast cancer | 2001 | 13 |
| 20 | 1997 | 19 |
About Jay Wasman
Jay Wasman is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine, Oncology, Surgery and Oral Surgery, having authored 63 papers that have together received 1.3k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (16 papers), Head and Neck Surgical Oncology (8 papers), Colorectal and Anal Carcinomas (6 papers), Salivary Gland Tumors Diagnosis and Treatment (6 papers), Lung Cancer Treatments and Mutations (5 papers), Thyroid Cancer Diagnosis and Treatment (5 papers), Brain Metastases and Treatment (4 papers) and Oral and Maxillofacial Pathology (4 papers). The work is most often cited by research in Otorhinolaryngology (138 citations), Endocrinology, Diabetes and Metabolism (279 citations), Oncology (446 citations), Biochemistry (67 citations) and Cancer Research (161 citations). Jay Wasman has collaborated with scholars based in United States, Canada and Greece. Frequent co-authors include Pierre Lavertu, Scot C. Remick, Pingfu Fu, P. Savvides, Afshin Dowlati, Govardhanan Nagaiah, Fadi W. Abdul‐Karim, Alan Siroy, Cliff A. Megerian and Robert Chapman. Their work appears in journals such as Journal of Clinical Oncology, Diagnostic Cytopathology, The Laryngoscope, American Journal of Otolaryngology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.